2014-04-01から1ヶ月間の記事一覧
Phase II study of vincristine sulfate liposome injection (Marqibo) and rituximab for patients with relapsed and refractory diffuse large B-Cell lymphoma or mantle cell lymphoma in need of palliative therapy.(Clin Lymphoma Myeloma Leuk 2014…
Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.(Ann Hematol 2014;93:803-810)自家幹細胞移植を併用した大量化学療法(HDT-ASCT)の後に臨床的…
Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.(Biol Blood Marrow Transplant 2014;20:536-542)標準的BEAMと自家造血…
Long-term follow-up of R-CHOP with bevacizumab as initial therapy for mantle cell lymphoma: clinical and correlative results.(Clin Lymphoma Myeloma Leuk 2014;14:107-113)[背景] 近年明らかになっている知見から、マントル細胞リンパ腫(MCL)では腫…
Phase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405).(Blood 2014;123:1665-1673)rituximab、bortezomib、modified hyper-CVADを組み合わせた寛解導入免疫化学…
Open-label, randomized, noninferiority study of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of advanced indolent NHL or MCL: the BRIGHT study.(Blood 2014;123:2944-2952)この多国間無作為化第3相臨床試験では、未治療の低悪性…
Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index.(Genes Chromosomes Cancer 2014;53:106-116) マントル細胞リンパ腫(M…
Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study(Br J Haematol 2014;165:489-496)新たに診断されR-CHOPで治療されたびまん性大細…
この論文は、MCL-2 trialの(2008年の報告に続く)長期観察報告です。2008年の報告はこちらです。 → 参照記事Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC…
Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC.(Ann Hematol 2014;93:233-242)自家幹細胞移植は若年のマントル細胞リンパ腫(MCL)患者にとって魅力的な治療選択肢の一つと考えられている。本研究はSFGM-TC study…
Nordic MCL-3 study: BEAM/C conditioning intensified with 90Y-Ibritumomab-Tiuxetan in responding non-CR patients followed by autologous transplant in mantle cell lymphoma.(Blood 2014;123:2953-2959)本研究の主な目的は、移植前にCRを達成出来な…
Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network.(JCO 2014, PMID 24687837)[目的] マントル細胞リンパ腫(MCL)はB細胞リンパ腫の中の独立した組織型で、予後…
Oral arsenic trioxide based regimen as salvage treatment for relapsed or refractory mantle cell lymphoma.(Ann Oncol 2014, PMID 24728036)[背景] マントル細胞リンパ腫(MCL)はaggressiveであり、再発・難治性の場合は予後不良である。[患者・方法] 大…
Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Proj…
Primary intraocular lymphoma: treatment outcomes with ocular radiation therapy alone (Leuk lymphoma 2014;55:795-801) 眼内原発リンパ腫(primary intraocular lymphoma; PIOL)のうち、他に中枢系浸潤が無いものの治療については議論の的となっている。…
Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma (Leuk lymphoma 2014;55:7…
Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404)(Leuk lymphoma 2014;55:768-7…
False-Positive [18F]Fluorodeoxyglucose-Avid Lymph Nodes on Positron Emission Tomography-Computed Tomography After Allogenic but Not Autologous Stem-Cell Transplantation in Patients With Lymphoma (JCO 2013, PMID 24248697) [目的] 造血幹細胞…
Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905 (JCO 2014;32:1242-1248) [目的…
Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: the long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial.(Leuk Lymphoma 2014, PMID 24628294)著者らは本試験にお…
Oral melphalan and dexamethasone grants extended survival with minimal toxity in AL amyloidosis: long-term results of a risk-adapted approach(haematologica 2014;99:743-50)経口メルファランとデキサメタゾンの併用療法は自家移植の適応が無いALア…
Random skin biopsy and bone marrow biopsy for diagnosis of intravascular large B cell lymphoma. (Ann Hematol 2011;90:417-21) 血管内リンパ腫(IVL)は節外性リンパ腫の稀なタイプであり、殆どの場合リンパ腫細胞が小血管の内腔で増殖する。IVLの診断に…
血管内大細胞型B細胞リンパ腫(intravascular large B-cell lymphoma; IVLBCL)はいわゆる「血管内リンパ腫」のことです。 Clinical features and treatment outcomes of intravascular large B-cell lymphoma: a single-center experience in Korea (Acta Hae…